1. Market Research
  2. > Pathology Industry

Bladder Cancer Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Clinical Trial, Biomarker, Cancer Diagnostic, Diagnostic, Oncology, Therapeutics.


 
1-10 of 41 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: Bladder Cancer Forecast in 18 Major Markets 2016-2026

Epiomic Epidemiology Series: Bladder Cancer Forecast in 18 Major Markets 2016-2026

  • $ 6 172
  • Industry report
  • May 2016
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bladder Cancer in 18 Major Markets Bladder Cancer is cancer arising in the urinary bladder, generally from urothelial cells. It is ...

Global Bladder Cancer Partnering 2010 to 2016

Global Bladder Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladde ...

Bladder Cancer Treatment Drugs Companies in China

Bladder Cancer Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Bladder Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

Bladder Cancer Treatment Drugs Industry Forecasts - China Focus

Bladder Cancer Treatment Drugs Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Bladder Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

Bladder Cancer Treatment Drugs Markets in China

Bladder Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Bladder Cancer Drug Pathway Analyzer

Bladder Cancer Drug Pathway Analyzer

  • $ 2 243
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 133 targeted molecular therapies known to affect more than 219 specific intracellular signaling pathways ...

Target Atlas in Bladder Cancer: A Competitive Outlook

Target Atlas in Bladder Cancer: A Competitive Outlook

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Bladder Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in bladde ...

Bladder Cancer Drug Pipeline Update

Bladder Cancer Drug Pipeline Update

  • $ 2 243
  • Industry report
  • February 2016
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the ...

About 1 400 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Canada

  • January 2016
    35 pages
  • Bladder Cancer  

    Cancer  

    Oncology  

  • Canada  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.